baber/WOPTO huggingface dataset:
Patent AU-2019204673-A1 (AU)
Title: A latching mechanism for the lid of a vehicle closure
Inventor: SUCKLING MARSHALL
IPC: E05B83/18
Filed: 2019-06-28
Abstract: The invention relates to a latching mechanism for the lid of a vehicle enclosure and has particular application to assisting in the prevention of inadvertent locking of the latching mechanism with the lock pin of the enclosure while a user attempts to open the lid. An intermediary member that engages with the release mechanism operating the latching mechanism is provided. This intermediary member has two surfaces, the first contacting the lock pin when the lid is closed and the second contacting the lock pin when the lid has been popped open. When the second surface contacts the lock pin, this prevents the engagement of the latching mechanism and allows the user to open the lid without having to also operate the release mechanism. 2\C2 2-026 Zoz Figure 2
Patent AU-2019216455-A1 (AU)
Title: Anticoagulant proteins and their use for treating diseases associated with the activation of neutrophils
Inventor: PIREAUX VALÉRIE
IPC: C07K14/81
Filed: 2019-02-01
Abstract: The present invention relates to a protein or polypeptide comprising an
Patent AU-2019224247-A1 (AU)
Title: Radio communication system, security proxy device, and relay device
Inventor: AONO HIROSHI
IPC: H04L12/66
Filed: 2019-02-20
Abstract: A vSEPP (210) encapsulates a predetermined element included in an original message received from a mobile communication network, and adds a first signature for a first message in which the predetermined element is encapsulated. A relay device (310) receives the first message, decapsulates the predetermined element included in the first message, and executes a change to the predetermined element. The relay device (310) adds a second signature for a second message including the changed predetermined element, and relays the second message to an HPLMN (30).
Patent AU-2019226392-A1 (AU)
Title: Method for obtaining regulatory T cells derived from thymic tissue and use of said cells as cell immunotherapy in immune system disorders
Inventor: CORREA ROCHA RAFAEL
IPC: C12N5/0783
Filed: 2019-03-01
Abstract: The present invention provides an
Patent AU-2019227618-A1 (AU)
Title: Method, apparatus, and electronic device for executing transactions based on blockchain
Inventor: QIU HONGLIN
IPC: G06Q20/02
Filed: 2019-02-26
Abstract: A node device of a blockchain receives a target transaction including transaction content, where at least a part of the transaction content comprises a content summary of target content stored in a third-party storage system connected to the blockchain. The target content corresponding to the content summary is queried from the third-party storage system. The target content is verified based on the content summary of the target content in the target transaction. If the verification of the target content succeeds, the target transaction is executed based on the transaction content in the target transaction. After the target transaction is executed, the target transaction is stored in a distributed database of the blockchain.
Patent AU-2019228842-A1 (AU)
Title: Ion conductor containing Li2B12H12 and LiBH4, method for producing same, and solid electrolyte for all-solid-state batteries, which contains said ion conductor
Inventor: NOGAMI GENKI
IPC: H01M10/0562
Filed: 2019-02-22
Abstract: The present invention is able to provide a method for producing an ion conductor containing Li
Patent AU-2019253892-A1 (AU)
Title: Compositions for modulating c90rf72 expression
Inventor: BENNETT FRANK C
IPC: C12N15/11
Filed: 2019-10-25
Abstract: Disclosed herein are compositions and methods for reducing expression of C90RF72 mRNA and protein in an animal with C90RF72 specific inhibitors. Such methods are useful to treat, prevent, or ameliorate neurodegenerative diseases in an individual in need thereof. Such C90RF72 specific inhibitors include antisense compounds. Examples of neurodegenerative diseases that can be treated, prevented, and ameliorated with the administration C90RF72 specific inhibitors include amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), corticalbasal degeneration syndrome (CBD), atypical Parkinsonian syndrome, and olivopontocerellar degeneration (OPCD).
Patent AU-2019263682-A1 (AU)
Title: Novel compounds
Inventor: MILLER DAVID
IPC: C07D249/14
Filed: 2019-05-03
Abstract: The present invention relates to substituted 5-membered nitrogen containing heteroaryl compounds, such as sulfonyl triazoles, where the heteroaryl ring is further substituted, optionally via a linking group such as -NH-, with a cyclic group which in turn is substituted at the α-position. The present invention further relates to associated salts, solvates, prodrugs and pharmaceutical compositions, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP
Patent AU-2019282530-A1 (AU)
Title: Methods of use of CD24 for the prevention and treatment of leukemia relapse
Inventor: LIU YANG
IPC: C07K16/30
Filed: 2019-06-03
Abstract: The present invention relates to the use of a CD24 protein for preventing or treating relapse of a cancer in a subject. The present invention also relates to the use of a CD24 protein for reducing cancer stem cell activity.
Patent AU-2019295576-A1 (AU)
Title: Compositions and methods for propagating insulin-producing islet cells and therapeutic uses thereof
Inventor: THAI NGOC
IPC: C12N5/071
Filed: 2019-06-20
Abstract: Disclosed herein are compositions and methods to differentiate pancreatic cells into functional insulin-producing CD133/Ki-67-positive activated islet proliferating cells (AIPCs) derived from isolated pancreatic islets and expand derived-AIPCs in
Patent AU-2019327494-A1 (AU)
Title: Combination therapies comprising PD-1-based chimeric proteins
Inventor: SCHREIBER TAYLOR
IPC: C07K14/00
Filed: 2019-08-29
Abstract: The present invention relates to,
Patent AU-2019335429-A1 (AU)
Title: Glass composition
Inventor: BOYD DANIEL
IPC: C03C3/23
Filed: 2019-09-04
Abstract: The present disclosure provides a glass composition that include from about 50 mol% to about 95 mol% of B2O3; from about 5 mol% to about 50 mol% of one or more glass components selected from the group consisting of: Li2O, Rb2O, K2O, Na2O, SrO, CaO, MgO, and ZnO. The glass composition includes less than 30 mol% of Rb2O. The glass composition is a quaternary system. The glass composition is a particulate material that includes particles that are from about 1 to about 50 µm in size. The glass composition loses at least 5 mass% within 24 hours when exposed to a buffered saline solution. The glass composition may be used to desensitize dentin. The present disclosure also provides a dentin-desensitizing composition.
Patent AU-2019336245-A1 (AU)
Title: Compositions and methods for delivering a nucleobase editing system
Inventor: BRYSON DAVID
IPC: C12N15/62
Filed: 2019-09-07
Abstract: The invention provides compositions and methods for delivering first and second polynucleotides each encoding a fragment of an A-to-G Base Editor fusion protein comprising one or more deaminases (e.g., adenosine deaminases) and nCas9, wherein the first polynucleotide encodes an N-terminal fragment of nCas9 fused to an intein-N of a split intein pair and the second polynucleotide encodes a C-terminal fragment of nCas9 fused to an intein-C of a split intein pair, and methods for delivering these fragments together with an sgRNA to a cell (e.g., AAV delivery), where the fragments are spliced together by a split intein system, thereby reconstituting a functional base editing system in the cell.
Patent AU-2019382590-A1 (AU)
Title: Device and method for reversibly connecting a rehabilitation mechanism to a bed, and method for operating a rehabilitation mechanism connected to a bed
Inventor: KÖNIG ALEXANDER
IPC: A61H1/02
Filed: 2019-11-21
Abstract: The invention relates to a device (1) and to a method for reversibly connecting a rehabilitation mechanism (30) to a bed (80), in particular to a hospital bed that can be moved into a vertical position. The device (1) comprises at least: at least one connection element (31) arranged on the rehabilitation mechanism (30); at least one receiving unit (12), which can be positioned at the side of and/or on the foot end (801) of the bed (80), the receiving unit (12) corresponding with the connection element (31); and a transport means (13) for transporting the rehabilitation mechanism (30) toward the bed (80) and away from the bed (80), the transport means (13) and/or the bed (80) being height-adjustable. The invention further relates to a method for operating a rehabilitation mechanism (30) connected to a bed (80) by means of a device (1) according to the invention. The invention advantageously enables easy, fast, reversible connection of a rehabilitation mechanism (30) to a conventional hospital bed (80), in particular a hospital bed that can be moved into a vertical position. The invention is also suitable, in particular, for quickly and economically retrofitting existing beds (80) with a robot system for kinesiotheraphy.
Patent AU-2019386379-A1 (AU)
Title: DPEP-1 binding agents and methods of use
Inventor: ROBBINS STEPHEN MARK
IPC: A61K38/10
Filed: 2019-12-02
Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
Patent AU-2019418587-A1 (AU)
Title: Compositions and methods of use of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5yl) methyl)-2,2-difluoroacetamide
Inventor: CHOUDRIE ROWENA FERNANDEZ
IPC: A61K47/12
Filed: 2019-12-30
Abstract: Provided herein are formulations and methods of use of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide or a stereoisomer or mixture of stereoisomers, pharmaceutically acceptable salt, tautomer, prodrug, isotopologue, solvate, hydrate, co-crystal, clathrate, or polymorph thereof.
Patent AU-2019453585-A1 (AU)
Title: Terminal
Inventor: UCHINO TOORU
IPC: H04W24/00
Filed: 2019-06-26
Abstract: A terminal (200) is provided with a control unit (250) which effects control to obtain a dormant state in which PDCCH monitoring is not performed at least in a cell. In the case of the dormant state, the control unit (250) ceases transmission of a specific uplink signal using the cell.
Patent WO-2020198814-A1 (WO)
Inventor: BATTEN PETER
IPC: B64C27/10
Filed: 2020-04-06
Abstract: The present disclosure is directed to a method for controlling rotors of a rotorcraft system comprising the steps of: receiving air velocity data, first and second rotors rotational angular velocity data, external air temperature data and rotorcraft altitude data by the control module; calculating air velocity over the plurality of blades based on the received data using the control module; calculating, based on the calculated air velocity, if one or more retreating blades of one of the first and second counterrotating rotors are generating insufficient lift; and sending one or more actuation signals from the control module to the electric motor and/or actuators of the other of the first and second counterrotating rotors to maintain a predetermined amount of lift.
Patent WO-2020257853-A1 (WO)
Title: Préparation et utilisation d'un matériau composite de zéolite et de biocharbon
Inventor: TOMLINSON DAVID
IPC: C05F3/00
Filed: 2020-06-25
Abstract: L'invention concerne un procédé de préparation d'un matériau composite comprenant la fourniture d'un matériau de biomasse et d'une zéolite qui sont mélangés ensemble. L'introduction du mélange de matériau de biomasse et de la zéolite dans une unité de pyrolyse et la pyrolyse de ce dernier, de telle sorte que le mélange devient un produit de carbonisation et une zéolite. Le fait de permettre au produit de carbonisation et à la zéolite obtenus d'être recuits afin de former le matériau composite. La zéolite qui est fournie à l'origine présente une dureté supérieure à quatre sur l'échelle de dureté Mohs, et est fournie en une quantité substantielle de telle sorte que la zéolite ne représente pas moins de cinquante pour cent en masse dudit matériau composite obtenu.
Patent WO-2021016671-A1 (WO)
Inventor: BALACHANDRAN CHANDRASHEKAR
IPC: A61F9/007
Filed: 2020-07-30
Abstract: Suture chirurgicale comprenant un corps allongé ayant une tête proximale pour ancrer la suture ; au moins une partie du corps allongé étant déformable pour créer une tête distale, la suture chirurgicale étant appropriée pour fixer un tissu entre la tête proximale et la tête distale. L'invention concerne également un procédé d'insertion de la suture chirurgicale décrite ci-dessus afin de refermer une incision, et un système de suture chirurgicale.
Patent WO-2021051169-A1 (WO)
Title: Container flooring
Inventor: BURTON PETER EDWARD
IPC: B27N3/14
Filed: 2020-09-18
Abstract: A method for providing container flooring for a container, including: providing a plurality of container flooring boards, each including a plurality of strand layers including strands of wood bonded together, at least a top strand layer and a bottom strand layer of the container flooring board having its strands substantially aligned in a first direction, and a dimension of the container flooring board in a second direction that is perpendicular to the first direction being selected to extend laterally between sides of the container in use; and arranging the container flooring boards inside the container, each container flooring board being positioned so that the strands of the top strand layer and the bottom strand layer are substantially aligned longitudinally relative to the container and the container flooring board extends laterally between the sides of the container, and respective edges of adjacent container flooring boards abut one another.
Patent AU-2020201347-A1 (AU)
Title: Modified J-chain
Inventor: KEYT BRUCE
IPC: C07K16/00
Filed: 2020-02-25
Abstract: The present invention concerns modified recombinant J-chain polypeptides, binding molecules, such as antibodies comprising the same, and their uses. 12137747_1 (GHMatters) P104256.AU.1
Patent AU-2020228672-A1 (AU)
Title: Network bandwidth apportioning
Inventor: SIVARAMAN VIJAY
IPC: H04L29/00
Filed: 2020-02-28
Abstract: A network bandwidth apportioning process executed by an Internet Service Provider (ISP), the process includes: defining a utility function representing, a relationship between allocated bandwidth of a predetermined network traffic class and a deemed utility of the class; determining, for each of the classes of network traffic, a corresponding portion of network bandwidth to be allocated to the class such that the sum of the deemed utilities for the classes is maximised for the determined portions; and apportioning network bandwidth of the ISP between the predetermined classes of network traffic according to the determined portions of network bandwidth. Network bandwidth apportioning further includes classifying each of the packets into predetermined classes of network traffic and allocating network bandwidth to each of the classes according to the determined portion of network bandwidth for the class.
Patent AU-2020242747-A1 (AU)
Title: Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
Inventor: HOWARD PHILIP WILSON
IPC: A61K47/68
Filed: 2020-03-13
Abstract: A compound of formula IV: as well as drug-linkers and conjugates comprising this compound, and the use of the conjugates in treating cancer.
Patent AU-2020249186-A1 (AU)
Title: Timber remediation
Inventor: WATERS PETER JOHN
IPC: B01D11/00
Filed: 2020-03-25
Abstract: Disclosed herein is a method of remediating chromated copper arsenate (CCA) treated timber. Particularly, the method comprises contacting the CCA timber with an oxidative solvent and an acidic solvent which provides remediated timber and a variety of extracts containing amongst other things the metals of concern. One or more of the steps is conducted using continuous counter current extraction (CCE).
Patent AU-2020256369-A1 (AU)
Title: Benzoxaborole compounds and uses thereof
Inventor: ALLEY M R K (DICKON)
IPC: A61P31/06
Filed: 2020-10-14
Abstract: BENZOXABOROLECOMPOUNDSANDUSESTHEREOF 
ABSTRACT 
Compounds whose structure comprises Formula 1l, 
R1 
t2 
0 O 
B 
5 X NH2 
Formula II 
or a compound whose structure comprises Formula III 
R1 OH 
R2 
OH 
B 
\0 
X NH2 
Formula III 
10 wherein X is selected from chloro, fluoro, bromo and iodo, R 1 and R 2 are each 
independently selected from H, -CH 3, -CH 2CH 3 , -CH 2CH2CH 3, or -CH(CH 3)2,; 
compositions containing them, their use in therapy, including their use as anti
mycobacterial agents, for example in the treatment of a mycobacterial infection in a 
mammal, and methods for the preparation of such compounds, are provided.  
15
Patent AU-2020273329-A1 (AU)
Title: A system for detecting a break in a rail
Inventor: HAY SID
IPC: G01N29/04
Filed: 2020-11-19
Abstract: A system 10 for detecting the presence of a rail end in a rail 18 of a railway track 20 includes 
a support structure 12 mountable to a component 14 of a rail vehicle 16. At least one 
magnetic field generator 22 is carried by the support structure 12 to generate a remanent 
magnetic field in the rail 18. A sensor arrangement 24 is carried by the support structure 12 in 
spaced relationship to the magnetic field generator 22 to detect magnetic flux leakage 
associated with the remanent magnetic field. The sensor arrangement 24 includes at least one 
pair of longitudinally spaced sensors, each sensor generating a measured signal based on the 
magnetic flux leakage detected by that sensor. A signal processing module 40 is responsive 
to the measured signals to calculate a differential signal from the measured signals of the 
sensors of the at least one pair of sensors. The differential signal is indicative of the presence 
of a rail end in the rail 18.
14 
36 
I48 
12 
Fig,.1 
/ 10 4 
26~ --
22. ............ 40 
24 ...28 64 
........ 30> 
20 ---1 ' Fig, 2 44 ....
Patent AU-2020276204-A1 (AU)
Title: Sodium-hydrogen exchanger 3 inhibitor compounds
Inventor: GAVARDINAS KOSTAS
IPC: A61K31/472
Filed: 2020-05-08
Abstract: The present invention relates to sodium-hydrogen exchanger 3 (NHE3) inhibitor compounds of the Formula: to pharmaceutical compositions comprising the compound and to the use of the compound for the treatment of certain diseases associated with elevated sodium and/or phosphate levels.
Patent AU-2020278898-A1 (AU)
Title: Phage and transduction particles
Inventor: KRAUSE HAABER JAKOB
IPC: C12N15/70
Filed: 2020-05-21
Abstract: The invention relates to the production of phage and transduction particles using DNAs (eg, plasmids and helper phage, mobile genetic elements (MGEs) or plasmids with chromosomally integrated helper phage genes), as well as the phage, helper phage, kits, compositions and methods involving these. The particles are particularly useful for delivering toxic payloads into target bacteria for antibacterial action. Embodiments enable production of highly pure compositions of such particles for medical or environmental use and for containment of the particles, which may be useful for containing antibacterial action.
Patent AU-2020286979-A1 (AU)
Title: Load-handling vehicle
Inventor: CHAILLOU VINCENT
IPC: E02F9/22
Filed: 2020-05-12
Abstract: The invention relates to a load-handling vehicle (1) comprising a wheeled chassis (2) and, supported by said chassis (2), - an internal combustion engine (4), - a mechanism (5) for transmitting power from the internal combustion engine (4) to the wheels (3) of the chassis (2), - a bucket (7), - a system for moving said bucket (7), - a control unit (9), - an accelerator pedal (10), - a control member (11) which can be manually actuated by the driver of the vehicle, - a system (12) for detecting movements of the bucket (7). The power transmission mechanism (5) is configured so that a reduction in the rotational speed of the internal combustion engine (4) results in a reduction in the torque supplied to the wheels (3) of the chassis (2) and the vehicle (1) comprises at least one operating mode in which the control unit (9) is configured, in accordance with the data provided by the system (12) for detecting the movements of the bucket (7) and the control instructions of the system for moving the bucket (7), to reduce the rotational speed of the engine (4) to a value lower than the set value for speed control corresponding to the position of the accelerator pedal (10).
Patent AU-2020297336-A1 (AU)
Title: Processes and intermediates for the preparation of 2-(2,6-dichlorophenyl)-1-((1S,3R)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl]ethenone
Inventor: COLE KEVIN PAUL
IPC: C07D217/16
Filed: 2020-06-11
Abstract: The embodiments of present invention provide processes and intermediates for the preparation of D1 PAM I: Formula (I).
Patent AU-2020310561-A1 (AU)
Title: Plate and system for covering vertical and horizontal surfaces
Inventor: GRANADOS PELAEZ DAVID
IPC: E04F15/02
Filed: 2020-06-29
Abstract: The invention relates to a covering plate (1) comprising: an outer decorative layer (2), a support layer (3) comprising magnesium oxide or magnesium oxide with perlite and/or vermiculite and/or cellulose, a layer of foam material (4) with an adhesive surface (5) and a plurality of perforations (6) and a barrier membrane (7) between the support layer and the layer of foam material. The support layer has a first thickness (31), following on from the decorative layer, which has a greater density than that of a second thickness (32) between the first thickness and the barrier membrane. The support layer is provided with a reinforcement structure (8) made of meshes or a fabric and located within the second thickness of the support layer. The invention also relates to a system comprising the covering plate.
Patent AU-2020329288-A1 (AU)
Title: Heterocyclic compounds as kinase inhibitors
Inventor: CHAKRAVARTY SARVAJIT
IPC: C07D239/49
Filed: 2020-08-13
Abstract: Heterocyclic compounds as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.
Patent AU-2020332008-A1 (AU)
Title: A target for use in firearms training
Inventor: BROOKS ALEX
IPC: F41J2/02
Filed: 2020-08-21
Abstract: Targets for use in training personnel in the operation of thermal imaging systems are described, the targets include: an internal cavity; an electrically powered heat source; the heat source is arranged to introduce heat to the internal cavity to cause warming of the target to thereby generate a heat signature.
Patent AU-2020340427-A1 (AU)
Title: PERK inhibiting compounds
Inventor: MULVIHILL MARK J
IPC: C07D213/74
Filed: 2020-08-28
Abstract: Provided herein are compounds of formula (I), compositions, and methods useful for inhibiting PERK and for treating related conditions, diseases, and disorders.
Patent AU-2020350769-A1 (AU)
Title: Anti-alpha-synuclein antibodies and methods of use thereof
Inventor: GUO JING
IPC: A61P25/16
Filed: 2020-09-18
Abstract: In one aspect, antibodies that specifically bind to a human alpha-synuclein protein are provided. In some embodiments, an anti-alpha-synuclein antibody binds to monomeric human alpha-synuclein protein, oligomeric human alpha-synuclein protein, soluble human alpha-synuclein protein, human alpha-synuclein protein fibrils, and human alpha-synuclein protein that is phosphorylated at Ser129 (pSer129) with high affinity. In some embodiments, an anti-alpha-synuclein antibody can specifically bind to or immunodeplete alpha-synuclein protein. In some embodiments, an anti-alpha-synuclein antibody can prevent or inhibit alpha-synuclein seeding.
Patent AU-2020368460-A1 (AU)
Title: Methods for the preparation of 5-Bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carboxylic acid
Inventor: CHEN YUZHONG
IPC: C07D405/04
Filed: 2020-10-16
Abstract: Described herein are novel methods of synthesizing 5-Bromo-2-(3-chloro-pyridin-2-yl)- 2H-pyrazole-3-carboxylic acid from pyrazole or pyrazole derivatives.